Liver Biopsy in Hodgkin's Lymphoma

Indications and Diagnostic Approaches

• The European Society for Medical Oncology recommends that liver biopsy in Hodgkin's lymphoma should be restricted to patients with elevated alkaline phosphatase or other clinical suspicion of hepatic involvement, as routine liver biopsy is no longer recommended for standard staging 1
• The National Comprehensive Cancer Network recommends that liver biopsy is NOT routinely indicated for staging Hodgkin's lymphoma in the modern era, with key indications including elevated alkaline phosphatase without other explanation, clinical suspicion of liver involvement based on symptoms or imaging findings 1, 2, 3
• The American Society of Clinical Oncology states that modern staging relies primarily on PET-CT imaging, which has largely replaced invasive procedures for detecting hepatic involvement 4, 5, 6
• The National Comprehensive Cancer Network guidelines suggest that CT scanning of chest, abdomen, and pelvis as mandatory baseline imaging, and bone marrow biopsy is now only required for stage IB, IIB, and stage III-IV disease 7, 2, 3, 8

Histopathologic Patterns and Diagnostic Yield

• The European Society for Medical Oncology notes that when liver involvement occurs in Hodgkin's lymphoma, the biopsy typically shows Reed-Sternberg cells within an inflammatory background comprising only 0.1-1% of the cellular population, and a mixed cellular infiltrate including lymphocytes, histiocytes, eosinophils, plasma cells, and fibroblasts 1

Practical Approach to Liver Assessment and Biopsy

• The National Comprehensive Cancer Network recommends that mandatory baseline tests include complete blood count with differential, comprehensive metabolic panel, and erythrocyte sedimentation rate 7, 8, 3, 6
• The American Society of Clinical Oncology states that for FDG-avid Hodgkin's lymphoma, PET-CT showing diffuse uptake, solitary mass, miliary lesions, or nodules indicates liver involvement, and PET-CT is now considered adequate for determination of liver involvement without biopsy confirmation in typical presentations 4, 5
• The European Society for Medical Oncology suggests that laparoscopy-assisted liver biopsy is superior to blind percutaneous biopsy when visual inspection can identify specific lesions, and multiple targeted biopsies can be obtained 6

Impact on Staging and Treatment

• The National Comprehensive Cancer Network guidelines state that documented liver involvement establishes stage IV disease, need for systemic chemotherapy, radiotherapy to residual masses, and a different prognostic category with implications for treatment intensity and surveillance 1, 2, 3, 4, 5, 6